#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hormone-dependent prostate cancer Mucopolysaccharidosis II PIK3CA related overgrowth spectrum Marginal zone lymphoma Sickle cell disease Non-Hodgkin's lymphoma Cutaneous T-cell lymphoma stage II Pneumonia Antiphospholipid syndrome Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Breast cancer Infective uveitis MELAS syndrome High-grade B-cell lymphoma Craniocerebral injury More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Treatment Primary hyperoxaluria – Treatment VEXAS syndrome – Life with Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Progressive supranuclear palsy Hereditary neuropathic amyloidosis – Basic Information Epidermolysis bullosa – Trials in Disease Chondrosarcoma – Trials in Disease Behcet’s syndrome – Life with Disease Methylmalonic acidaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lisdexamfetamine Dimesylate Astegolimab F125/10 Amifostine Thiol Mecillinam Tanimilast Keto-Valine Calcium Colesevelam Histidine Bjt-778 Epinephrine Hydrochloride Tozorakimab CYCLIZINE HYDROCHLORIDE Ttx-030 Flutafuranol (18F) Casirivimab Sodium Oxybate BROLUCIZUMAB Dolutegravir Gadoteridol More therapies…

    Learn about Your Condition

    Cleft lip and palate Peritoneal cancer index Plasmablastic lymphoma Acromegaly Angiopathy Transplant rejection Haemorrhage Tertiary adrenal insufficiency Osteomyelitis acute Hairy cell leukaemia Radiation skin injury Plasma cell myeloma Appendicitis Renal cancer recurrent Fibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Meningococcal immunisation

  • Study on Immune Response Differences to Meningococcal Group B Vaccine in Healthy Transgender and Cisgender Adults Aged 18-40

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
    • Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
    • Recombinant Neisseria Meningitidis Group B Nada Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
    Belgium

  • Study on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • TETANUS TOXOID
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Finland Germany Hungary Spain

  • Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)
    • Hepatitis B Surface Antigen (Rdna)
    • Neisseria Meningitidis, Serogroup C, Polysaccharide, Conjugated To Tetanus Toxoid
    Czechia Denmark Finland Germany Poland Spain

  • Study on Immune Response to Meningococcal Vaccine in Elderly with Invasive Meningococcal Disease Using MenACWY-TT Conjugate Vaccine

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    • Neisseria Meningitidis Group W-135 Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!